Michel Engeln - Related publications

University of Maryland, Baltimore 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
32 most relevant papers in past 60 days:
Year Citation  Score
2022 Buck SA, Erickson-Oberg MQ, Bhatte SH, McKellar CD, Ramanathan VP, Rubin SA, Freyberg Z. Roles of VGLUT2 and Dopamine/Glutamate Co-Transmission in Selective Vulnerability to Dopamine Neurodegeneration. Acs Chemical Neuroscience. PMID 34994539 DOI: 10.1021/acschemneuro.1c00741   
2022 Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models. Molecular Medicine Reports. 25. PMID 35039876 DOI: 10.3892/mmr.2022.12607   
2022 Ferreira AFF, Singulani MP, Ulrich H, Feng ZP, Sun HS, Britto LR. Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model. Molecular Neurobiology. PMID 35000153 DOI: 10.1007/s12035-022-02723-8   
2022 Soti M, Ranjbar H, Kohlmeier KA, Shabani M. Parkinson's disease related alterations in cannabinoid transmission. Brain Research Bulletin. 178: 82-96. PMID 34808322 DOI: 10.1016/j.brainresbull.2021.11.009   
2022 Wu J, Zhou C, Guo T, Guan X, Gao T, Bai X, Wu H, Chen J, Wen J, Liu X, Gu L, Song Z, Xuan M, Gu Q, Huang P, et al. Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson's disease. Brain Imaging and Behavior. PMID 34973120 DOI: 10.1007/s11682-021-00610-9   
2022 Rincón-Cortés M, Grace AA. Postpartum scarcity-adversity disrupts maternal behavior and induces a hypodopaminergic state in the rat dam and adult female offspring. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 47: 488-496. PMID 34703012 DOI: 10.1038/s41386-021-01210-3   
2022 Skelton PD, Tokars V, Parisiadou L. LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights. Cells. 11. PMID 35011731 DOI: 10.3390/cells11010169   
2022 Ashraf-Uz-Zaman M, Ji G, Tidwell D, Yin L, Thakolwiboon S, Pan J, Junell R, Griffin Z, Shahi S, Barthels D, Sajib MS, Trippier PC, Mikelis CM, Das H, Avila M, et al. Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. Acs Chemical Neuroscience. PMID 34978174 DOI: 10.1021/acschemneuro.1c00647   
2022 Gibson AS, West PJ, Keefe KA. Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation. Psychopharmacology. PMID 34985532 DOI: 10.1007/s00213-021-06055-8   
2022 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends in Endocrinology and Metabolism: Tem. 33: 147-157. PMID 34949514 DOI: 10.1016/j.tem.2021.11.005   
2022 Gatica RI, Aguilar-Rivera M, Henny P, Fuentealba JA. Susceptibility to express amphetamine locomotor sensitization correlates with dorsolateral striatum bursting activity and GABAergic synapses in the globus pallidus. Brain Research Bulletin. 179: 83-96. PMID 34920034 DOI: 10.1016/j.brainresbull.2021.12.005   
2022 Mendonça IP, Paiva IHR, Duarte-Silva EP, Melo MG, Silva RSD, Oliveira WH, Costa BLDSAD, Peixoto CA. Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsońs disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity. International Immunopharmacology. 102: 108415. PMID 34890997 DOI: 10.1016/j.intimp.2021.108415   
2022 Lisek M, Boczek T, Stragierowicz J, Wawrzyniak J, Guo F, Klimczak M, Kilanowicz A, Zylinska L. Hexachloronaphthalene (HxCN) impairs the dopamine pathway in an in vitro model of PC12 cells. Chemosphere. 287: 132284. PMID 34563782 DOI: 10.1016/j.chemosphere.2021.132284   
2022 Luo H, Peng C, Xu X, Peng Y, Shi F, Li Q, Dong J, Chen M. The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3. Molecular Neurobiology. PMID 35040040 DOI: 10.1007/s12035-021-02689-z   
2022 De la Torre-Iturbe S, Vázquez-Roque RA, De la Cruz-López F, Flores G, Garcés-Ramírez L. Dendritic and behavioral changes in rats neonatally treated with homocysteine; A proposal as an animal model to study the attention deficit hyperactivity disorder. Journal of Chemical Neuroanatomy. 119: 102057. PMID 34871732 DOI: 10.1016/j.jchemneu.2021.102057   
2022 Yin S, Han C, Xia Y, Wan F, Hu J, Kou L, Sun Y, Wu J, Li Y, Zhou Q, Xiong N, Huang J, Wang T. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease? Molecular Neurobiology. PMID 34984583 DOI: 10.1007/s12035-021-02670-w   
2022 Sigvard AK, Nielsen MØ, Gjedde A, Bojesen KB, Fuglø D, Tangmose K, Kumakura Y, Heltø K, Ebdrup BH, Jensen LT, Rostrup E, Glenthøj BY. Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response. Biological Psychiatry. 91: 236-245. PMID 34743917 DOI: 10.1016/j.biopsych.2021.08.023   
2022 Hansen CA, Miller DR, Annarumma S, Rusch CT, Ramirez-Zamora A, Khoshbouei H. Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment. Journal of Neurology. PMID 35039902 DOI: 10.1007/s00415-022-10963-w   
2022 Sharma K, Fallon SJ, Davis T, Ankrett S, Munro G, Christopher G, Coulthard E. Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson's disease according to task demands. Psychopharmacology. PMID 35006304 DOI: 10.1007/s00213-021-06054-9   
2022 Conway JA, Kramer ER. Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic. Neural Regeneration Research. 17: 1462-1467. PMID 34916419 DOI: 10.4103/1673-5374.327330   
2022 Dyomina AV, Kovalenko AA, Zakharova MV, Postnikova TY, Griflyuk AV, Smolensky IV, Antonova IV, Zaitsev AV. MTEP, a Selective mGluR5 Antagonist, Had a Neuroprotective Effect but Did Not Prevent the Development of Spontaneous Recurrent Seizures and Behavioral Comorbidities in the Rat Lithium-Pilocarpine Model of Epilepsy. International Journal of Molecular Sciences. 23. PMID 35008924 DOI: 10.3390/ijms23010497   
2022 Peng H, Li Y, Ji W, Zhao R, Lu Z, Shen J, Wu Y, Wang J, Hao Q, Wang J, Wang W, Yang J, Zhang X. Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson's Disease. Acs Nano. PMID 34985280 DOI: 10.1021/acsnano.1c08473   
2022 Weissbach A, Steinmeier A, Pauly M, Al-Shorafat DM, Saranza G, Lang A, Brüggemann N, Tadic V, Klein C, Münchau A, Bäumer T, Brown MJN. Longitudinal evaluations of somatosensory-motor inhibition in Dopa-responsive dystonia. Parkinsonism & Related Disorders. 95: 40-46. PMID 34999542 DOI: 10.1016/j.parkreldis.2021.12.016   
2022 Spitta G, Gleich T, Zacharias K, Butler O, Buchert R, Gallinat J. Extrastriatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder and Individuals at High Risk. Neuropsychobiology. 1-10. PMID 35016171 DOI: 10.1159/000521103   
2022 Zhao D, Zhang M, Yang L, Zeng M. GPR68 Improves Nerve Damage and Myelination in an Immature Rat Model Induced by Sevoflurane Anesthesia by Activating cAMP/CREB to Mediate BDNF. Acs Chemical Neuroscience. PMID 35025202 DOI: 10.1021/acschemneuro.1c00830   
2022 Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, et al. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. Molecular Neurodegeneration. 17: 7. PMID 35012605 DOI: 10.1186/s13024-021-00509-5   
2022 Tian Q, Tang HL, Tang YY, Zhang P, Kang X, Zou W, Tang XQ. Hydrogen Sulfide Attenuates the Cognitive Dysfunction in Parkinson's Disease Rats via Promoting Hippocampal Microglia M2 Polarization by Enhancement of Hippocampal Warburg Effect. Oxidative Medicine and Cellular Longevity. 2022: 2792348. PMID 35028004 DOI: 10.1155/2022/2792348   
2022 Shi S, Chen T, Zhao M. The Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation. Neurochemical Research. PMID 34982394 DOI: 10.1007/s11064-021-03513-9   
2022 Campos-Ordoñez T, Alcalá E, Ibarra-Castañeda N, Buriticá J, González-Pérez Ó. Chronic exposure to cyclohexane induces stereotypic circling, hyperlocomotion, and anxiety-like behavior associated with atypical c-Fos expression in motor- and anxiety-related brain regions. Behavioural Brain Research. 418: 113664. PMID 34780858 DOI: 10.1016/j.bbr.2021.113664   
2022 Oggiano M, Buccheri C, Alleva E, Adriani W. Dopaminergic modulation of the circadian activity and sociability: Dissecting parental inheritance versus maternal styles as determinants of epigenetic influence. Behavioural Brain Research. 417: 113623. PMID 34624423 DOI: 10.1016/j.bbr.2021.113623   
2022 Li X, Gao D, Paudel YN, Li X, Zheng M, Liu G, Ma Y, Chu L, He F, Jin M. Anti-Parkinson's Disease Activity of Extracts in the MPTP-Induced Zebrafish Model. Acs Chemical Neuroscience. PMID 35044760 DOI: 10.1021/acschemneuro.1c00656   
2022 Xu L, Liu X, Guo C, Wang C, Zhao J, Zhang X, Li W, Zhang P, Gu R. Inhibition of ROCK2 kinase activity improved behavioral deficits and reduced neuron damage in a DEACMP rat model. Brain Research Bulletin. PMID 34990732 DOI: 10.1016/j.brainresbull.2021.12.018